Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
Open Access
- 1 October 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 1 (3) , e25
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Pilot trial of low‐dose naltrexone and quality of life in multiple sclerosisAnnals of Neurology, 2010
- The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trialMultiple Sclerosis Journal, 2010
- A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisMultiple Sclerosis Journal, 2008
- Low-Dose Naltrexone Therapy Improves Active Crohn's DiseaseAmerican Journal of Gastroenterology, 2007
- Interim Report on Clinic Intake and Safety Data Collected from 17 NIDA-Funded Naltrexone Studies1976